Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01523977
Title Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Prednisone

Everolimus

Vincristine Sulfate

Doxorubicin

Pegaspargase

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
UCSF San Francisco California 94143 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 United States Details
Boston Children's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York New York 12549 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field